Profit and Loss
| Natco Pharma Ltd Industry: (Pharmaceuticals - Indian - Bulk Drugs & Formln) |
|---|
|
BSE Code:
524816
ISIN Demat:
INE987B01026
Book Value(₹): 501.20 NSE Symbol:
NATCOPHARM
Div & Yield(%):
0.58
Market Cap(₹ Cr): 15,395.30 P/E(TTM):
17.26
EPS(TTM):
45.47
Face Value(₹): 2.00 |
| Dec 26 (₹ Cr) | Dec 25 (₹ Cr) | Dec 24 (₹ Cr) | Dec 23 (₹ Cr) | Dec 22 (₹ Cr) | |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 3,594.60 | 4,094.50 | 3,568.90 | 2,351.00 | 1,767.80 |
| Other Income | 281.10 | 321.30 | 104.70 | 85.50 | 94.60 |
| Stock Adjustments | 69.20 | -11.60 | -17.20 | -34.60 | 5.50 |
| Total Income | 3,944.90 | 4,404.20 | 3,656.40 | 2,401.90 | 1,867.90 |
| EXPENDITURE : | |||||
| Raw Materials | 642.90 | 581.70 | 557.30 | 495.10 | 540.10 |
| Power and Fuel Cost | 96.90 | 93.10 | 88.90 | 81.90 | 76.40 |
| Other Manufacturing Expenses | 279.90 | 217.70 | 179.80 | 150.30 | 148.70 |
| Selling and Administration Expenses | 618.50 | 444.10 | 483.70 | 290.70 | 309.10 |
| Miscellaneous Expenses | 129.00 | 86.70 | 150.10 | 28.00 | 75.90 |
| Employee Benefit Expenses | 591.70 | 515.30 | 454.90 | 425.70 | 410.10 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 1,586.00 | 2,465.60 | 1,741.70 | 930.20 | 307.60 |
| Interest | 32.30 | 19.60 | 14.50 | 8.60 | 13.30 |
| Gross Profit | 1,553.70 | 2,446.00 | 1,727.20 | 921.60 | 294.30 |
| Depreciation | 189.60 | 220.00 | 171.90 | 150.90 | 138.40 |
| Profit Before Tax | 1,364.10 | 2,226.00 | 1,555.30 | 770.70 | 155.90 |
| Current Tax | 268.40 | 407.50 | 284.80 | 133.10 | 32.50 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -185.80 | -31.90 | -36.10 | 0.50 | -15.70 |
| Reported Net Profit | 1,281.50 | 1,850.40 | 1,306.60 | 637.10 | 139.10 |
| Extraordinary Items | -18.23 | 104.58 | -2.12 | 14.71 | 33.80 |
| Adjusted Net Profit | 1,299.73 | 1,745.82 | 1,308.72 | 622.39 | 105.30 |
| Adjustment below Net Profit | 15.30 | 3.00 | -49.70 | -1.00 | 0.40 |
| Profit/Loss Balance carried down | 5,972.20 | 4,226.30 | 3,134.60 | 2,587.10 | 2,520.50 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 89.60 | 107.50 | 165.20 | 88.60 | 72.90 |
| P & L Balance carried down | 7,179.40 | 5,972.20 | 4,226.30 | 3,134.60 | 2,587.10 |
| Dividend | 0.00 | 0.00 | 170.20 | 100.40 | 82.10 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 250.00 | 300.00 | 475.00 | 275.00 | 225.00 |
| Dividend Per Share(Rs) | 5.00 | 6.00 | 9.50 | 5.50 | 4.50 |
| Earnings Per Share-Unit Curr | 71.59 | 103.37 | 72.99 | 34.91 | 7.62 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 477.80 | 409.72 | 312.42 | 257.64 | 229.69 |
| Book Value(Adj)-Unit Curr | 473.94 | 406.41 | 309.89 | 255.56 | 227.83 |